Beyond Air, Inc.
For the period ended Mar 31, 2026. Filed Jun 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 26, 2026
XAIR$2.52+10.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in thousands)
| Year Ended March 31, 2026 · Year Ended March 31, 2025 | ||||
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | $(34,334) | $(48,479) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation | 3,047 | 2,999 | ||
| Stock-based compensation | 5,282 | 9,146 | ||
| Amortization of debt discount and accretion of debt issuance costs | 551 | 1,028 | ||
| Amortization of licensed right to use technology | 204 | 205 | ||
| Amortization of operating lease assets | 398 | 367 | ||
| Change in fair value of warrant liability | (35) | (237) | ||
| Change in fair value of derivative liability | 1,395 | (1,314) | ||
| Unrealized loss on marketable securities | - | 60 | ||
| Provision for inventory losses | 672 | 177 | ||
| Provision for bad debt | 91 | - | ||
| Foreign currency adjustments | (119) | - | ||
| Loss on extinguishment of debt | 165 | 2,447 | ||
| Impairment of fixed assets | - | 505 | ||
| Loss on disposal of fixed assets | 431 | 334 | ||
| Paid in kind interest | 1,762 | 696 | ||
| Changes in: | ||||
| Inventory | 1,110 | (466) | ||
| Accounts receivable | (468) | (390) | ||
| Other current assets and prepaid expenses | 683 | 1,048 | ||
| Accounts payable | 267 | 399 | ||
| Accrued expenses | 1,127 | (6,358) | ||
| Operating lease liabilities | (373) | (385) | ||
| Net cash used in operating activities | (18,144) | (38,218) | ||
| Cash flows from investing activities: | ||||
| Purchase of marketable securities | (4,053) | (30,878) | ||
| Proceeds from sale of marketable securities | 1,404 | 51,656 | ||
| Security deposits made on operating leases | - | 10 | ||
| Purchase of property and equipment | (1,025) | (5,883) | ||
| Net cash (used in)/provided by investing activities | (3,674) | 14,905 | ||
| Cash flows from financing activities: | ||||
| Proceeds from issuance of common stock through at the market offerings, net | 8,135 | 2,151 | ||
| Proceeds from the sale of common stock of NeuroNos | 700 | 2,000 | ||
| Proceeds from issuance of common stock and pre-funded warrants through securities purchase, net | 4,500 | 18,858 | ||
| Proceeds from issuance of common stock through exercise of warrants | 2,869 | 365 | ||
| Proceeds from issuance of common stock warrants | 90 | - | ||
| Proceeds from long term loan | 14,000 | 11,324 | ||
| Debt issuance costs | (996) | - | ||
| Payment of loan | (208) | (18,052) | ||
| Net cash provided by financing activities | 29,090 | 16,646 | ||
| Effect of exchange rate changes on cash and cash equivalents | 194 | (45) | ||
| Increase/(decrease) in cash, cash equivalents and restricted cash | 7,466 | (6,712) | ||
| Cash, cash equivalents and restricted cash at beginning of year | 4,896 | 11,608 | ||
| Cash, cash equivalents and restricted cash at end of year | $12,362 | $4,896 | ||
| Supplemental disclosure of non-cash investing and financing activities: | ||||
| Debt discount | $1,094 | $3,249 | ||
| Derivative liability | $775 | $ | - | |
| Short term finance liability | $457 | $693 | ||
| Fixed assets recorded in accounts payable and accrued expenses | $398 | $396 | ||
| Right-of-use assets acquired under operating leases | $139 | $ | - | |
| Debt principal balance converted to equity | $1,171 | $ | - | |
| Interest paid | $423 | $1,197 | ||
| Income taxes paid | $ | - | $ | - |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.